Swedish Match, a subsidiary of Philip Morris International, makes the ZYN pouches. The FDA's approval noted the patches posed ...

When John,* 43, first heard about Zyn from a friend a couple years ago, it struck him as a “much better alternative to chewing [tobacco],” he tells SELF, which he’d previously done on occasion to get ...

HRMY isn't your typical cannabis play - its synthetic CBD gel targets rare brain disorders with no approved therapies.

Philip Morris International Inc. rated Hold with $170 target: strong smoke-free growth & margins vs. peers. Click for PM ...

Philip Morris International's U.S. business, PMI U.S., unveiled its new "Invested in America" advertising campaign, ...

Philip Morris International Inc. (NYSE:PM) ranks among the best FMCG stocks to buy. Analysts at BofA Securities raised their ...

As of Tuesday, convenience-store retailers could remove corrective statement signage from their stores. The signs had been ...

In January 2025, the US Food and Drug Administration (FDA) authorized the marketing of nicotine pouches to individuals aged 21 years and older. However, the use of nicotine pouches among teens appears ...

In a surprise post this afternoon, new FDA Commissioner Dr Martin Makary announced a completed pilot at the FDA of a generative AI-based system for speeding up drug review - and plans to roll out ...

At its second attempt, Astellas won FDA approval for its first-in-class cancer therapy, Vyloy, which got the green light for claudin 18.2+ gastric cancer ...